Skip to main content
Log in

The pharmacokinetics of atovaquone and proguanil in pregnant women with acute falciparum malaria

  • Pharmacokinetics and Disposition
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

Abstract

Objective

To determine the pharmacokinetic properties of atovaquone, proguanil, and the triazine metabolite cycloguanil in women with recrudescent multi-drug resistant falciparum malaria during the second and third trimesters of pregnancy treated by artesunate-atovaquone-proguanil.

Methods

Serial plasma concentrations of atovaquone, proguanil and cycloguanil were measured in 24 women at baseline and after the final dose of the 3-day treatment with atovaquone (20 mg/kg/day) plus proguanil (8 mg/kg/day) plus artesunate (4 mg/kg/day) daily.

Results

The triple combination was well tolerated and highly effective. The outcomes of pregnancy were all normal. Population mean (± SEM) oral clearance (Cl/F) estimates were 313±33 ml/h/kg and 1109±43 ml/h/kg, total apparent volume of distribution (Vd/F) 13.0±1.3 l/kg and 22.9±1.4 l/kg, and terminal elimination half-life; 29.1 h and 14.3 h, for atovaquone and proguanil, respectively. Using conventional and population pharmacokinetic analyses, Cl/F and Vd/F estimates for both drugs were approximately twice, and plasma concentrations less than half those reported previously in healthy subjects and patients with acute malaria.

Conclusion

Artesunate-atovaquone-proguanil is a promising treatment for multi-drug resistant falciparum malaria during pregnancy, but the dose of atovaquone-proguanil may need to be increased.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

a

Similar content being viewed by others

References

  1. Brockman A, Price RN, van Vugt M, Heppner DG, Walsh DS, Sookto P, Wimonwattrawatee T, Looareesuwan S, White NJ, Nosten F (2000) Plasmodium falciparum antimalarial drug susceptibility on the north-western border of Thailand during five years of extensive artesunate-mefloquine use. Trans R Soc Trop Med Hyg 94:537–544

    CAS  PubMed  Google Scholar 

  2. McGready R, Brockman A, Cho T, Cho D, van Vugt M, Luxemburger C, Chongsuphajaisiddhi T, White NJ, Nosten F (2000) Randomized comparison of mefloquine-artesunate combination versus quinine in treatment of multi-drug resistant falciparum malaria in pregnancy. Trans R Soc Trop Med Hyg 94:689–693

    CAS  PubMed  Google Scholar 

  3. McGready R, Cho T, Khan Keo N, Thwai KL, S L, White NJ, Nosten F (2001) Artemisinin antimalarials in pregnancy: a prospective treatment study of 539 episodes of multidrug-resistant P. falciparum. Clin Infec Dis 33:2009–2016

    CAS  Google Scholar 

  4. Looareesuwan S, Viravan C, Webster HK, Kyle DE, Hutchinson DB, Canfield CJ (1996) Clinical studies of atovaquone, alone or in combination with other antimalarial drugs, for treatment of acute uncomplicated malaria in Thailand. Am J Trop Med Hyg 54:62–66

    CAS  PubMed  Google Scholar 

  5. Product information, Malarone (atovaquone and proguanil hydrochloride). Physician's Desk Reference 2001; Medical Economics Company, Inc. Montvale (NJ), USA

  6. van Vugt M, Edstein MD, Proux S, Lay K, Ooh M, Loorareesuwan S, White NJ, Nosten F (1999) Absence of an interaction between artesunate and atovaquone–proguanil. Eur J Clin Pharmacol 55:469–474

    PubMed  Google Scholar 

  7. van Vugt M, Leonardi E, Phaipun L, Slight T, Thway KL, McGready R, Brockman A, Villegas L, Looareesuwan S, White NJ, Nosten F (2002) Treatment of uncomplicated multidrug-resistant falciparum malaria with artesunate-atovaquone-proguanil. Clin Infect Dis 35:1498–1504

    PubMed  Google Scholar 

  8. McGready R, Khan Keo N, Villegas L, White NJ, Looareesuwan S, Nosten F (2003) Artesunate–atovaquone–proguanil rescue treatment of multidrug resistant falciparum malaria in pregnancy: a preliminary report. Trans R Soc Trop Med Hyg (in press)

  9. Nosten F, ter Kuile F, Maelankirri L, Decludt B, White NJ (1991) Malaria during pregnancy in an area of unstable endemicity. Trans R Soc Trop Med Hyg 85:424–429

    CAS  PubMed  Google Scholar 

  10. Price RN, Nosten F, Luxemburger C, van Vugt M, Phaipun L, Chongsuphajaisiddhi T, White NJ (1997) Artesunate/mefloquine treatment of multi-drug resistant falciparum malaria. Trans R Soc Trop Med Hyg 91:574–577

    CAS  PubMed  Google Scholar 

  11. Brockman A, Paul RE, Anderson TJ, Hackford I, Phaiphun L, Looareesuwan S, Nosten F, Day KP (1999) Application of genetic markers to the identification of recrudescent Plasmodium falciparum infections on the northwestern border of Thailand. Am J Trop Med Hyg 60:14–21

    CAS  PubMed  Google Scholar 

  12. Nosten F, McGready R, Simpson JA, Thwai KL, Balkan S, Cho T, Hkirijaroen L, Looareesuwan S, White NJ (1999) Effects of Plasmodium vivax malaria in pregnancy. Lancet 354:546–549

    CAS  PubMed  Google Scholar 

  13. Rolan PE, Mercer AJ, Weatherley BC, Holdich T, Meire H, Peck RW, Ridout G, Posner J (1994) Examination of some factors responsible for a food-induced increase in absorption of atovaquone. Br J Clin Pharmacol 37:13–20

    CAS  PubMed  Google Scholar 

  14. Shanks GD, Edstein MD, Chedester AL, Smith CD, Corcoran KD, Ngampochjana M, Hansukjariya P, Sattabongkot J, Webster HK (1994) Proguanil plus sulfamethoxazole is not causally prophylactic in the Macaca mulatta-Plasmodium cynomolgi model. Am J Trop Med Hyg 50:641–645

    CAS  PubMed  Google Scholar 

  15. Taylor RB, Moody RR, Ochekpe NA (1987) Determination of proguanil and its metabolites cycloguanil and 4-chlorophenylbiguanide in plasma, whole blood and urine by HPLC. J Chromatogr 416:394–399

    CAS  Google Scholar 

  16. Lindstrom ML, Bates DM (1990) Nonlinear mixed effects models for repeated measures data. Biometrics 46:673–687

    CAS  PubMed  Google Scholar 

  17. McGready R, Cho T, Samuel, Villegas L, Brockman A, van Vugt M, Looareesuwan S,White NJ, Nosten F (2001) Randomized comparison of quinine-clindamycin versus artesunate in the treatment of falciparum malaria in pregnancy. Trans R Soc Trop Med Hyg 95:651–656

    CAS  PubMed  Google Scholar 

  18. Hussein Z, Eaves J, Hutchinson D, Canfield C (1997) Population pharmacokinetics of atovaquone in patients with acute malaria caused by Plasmodium falciparum. Clin Pharm Therapeut 61:518–530

    CAS  Google Scholar 

  19. Hussein Z, Eaves CJ, Hutchinson DB, Canfield CJ (1996) Population pharmacokinetics of proguanil in patients with acute P. falciparum malaria after combined therapy with atovaquone. Br J Clin Pharmacol 42:589–597

    CAS  PubMed  Google Scholar 

  20. Sabcharoen A, Attanath P, Phanuaksook P, Chanthavanich P, Poonpanich Y,Mookmanee D, Chongsuphajaisiddhi T, Sadler BM, Hussein Z, Canfield CJ, Hutchinson DB (1998) Efficacy and pharmacokinetics of atovaquone and proguanil in children with multidrug-resistant Plasmodium falciparum malaria. Trans R Soc Trop Med Hyg 92:201–206

    CAS  PubMed  Google Scholar 

  21. Ward SA, Helsby NA, Skjelbo E, Brosen K, Gram LF, Breckenridge AM (1991) The activation of the biguanide antimalarial proguanil co-segregates with the mephenytoin oxidation polymorphism—a panel study. Br J Clin Pharmacol 31:689–692

    CAS  PubMed  Google Scholar 

  22. Edstein MD, Shanks GD, Teja-Isavadharm P, Rieckmann KH, Webster HK (1994) Oxidative activation of proguanil and dapsone acetylation in Thai soldiers. Br J Clin Pharmacol 37:67–70

    CAS  PubMed  Google Scholar 

  23. Wangboonskul J, White NJ, Nosten F, ter Kuile F, Moody RR, Taylor RB (1993) Single dose pharmacokinetics of proguanil and its metabolites in pregnancy. Eur J Clin Pharmacol 44:247–251

    CAS  PubMed  Google Scholar 

  24. Wattanagoon Y, Taylor RB, Moody RR, Ochekpe NA, Looareesuwan S, White NJ (1987) Single dose pharmacokinetics of proguanil and its metabolites in healthy subjects. Br J Clin Pharmacol 24:775–780

    CAS  PubMed  Google Scholar 

  25. Karbwang J, White NJ (1990) Clinical pharmacokinetics of mefloquine. Clin Pharmacokinet 19:264–279

    CAS  PubMed  Google Scholar 

  26. McGready R, Stepniewska K, Seaton E, Cho T, Cho D, Ginsburg A, Edstein MD, Ashley E, Looareesuwan S, White NJ, Nosten F. (2003) Pregnancy and use of oral contraceptives reduces the biotransformation of proguanil to cycloguanil. Eur J Clin Pharm (this issue)

  27. Jones K, Ward SA (2002) Biguanide-atovaquone synergy against Plasmodium falciparum in vitro. Antimicrob Agents Chemother 46:2700–2703

    CAS  PubMed  Google Scholar 

  28. White NJ, van Vugt M, Ezzet F (1999) Clinical pharmacokinetics and pharmacodynamics of artemether-lumefantrine. Clin Pharmacokinet 37:105–125

    CAS  PubMed  Google Scholar 

Download references

Acknowledgements

We thank the staff of the Shoklo Malaria Research Unit antenatal clinics for their help. This investigation was part of the Wellcome Trust Mahidol University Oxford Tropical Medicine Research Programme supported by the Wellcome Trust of Great Britain.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to N. J. White.

Rights and permissions

Reprints and permissions

About this article

Cite this article

McGready, R., Stepniewska, K., Edstein, M.D. et al. The pharmacokinetics of atovaquone and proguanil in pregnant women with acute falciparum malaria. Eur J Clin Pharmacol 59, 545–552 (2003). https://doi.org/10.1007/s00228-003-0652-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00228-003-0652-9

Keywords

Navigation